Francisella tularensis LPS activators encompass a variety of compounds that directly or indirectly boost the immune system's recognition and response to the LPS of this bacterium. A significant aspect of this response revolves around the TLR4 signaling pathway. Chemicals such as Monophosphoryl lipid A (MPLA) and Lipid IVa directly stimulate the TLR4 pathway, priming the immune system for a more robust response to LPS molecules. These compounds essentially amplify the existing recognition systems in place for bacterial LPS, ensuring that even subtle or less immunogenic LPS structures, such as those of Francisella tularensis, are effectively recognized.
Additionally, the immune system often relies on a multi-faceted approach to detect and combat bacterial invasions. Hence, chemicals like Poly I:C, and Pam3CSK4, which activate TLR9, TLR3, and TLR1/TLR2 pathways, respectively, provide a broader activation spectrum. While not directly targeting the TLR4 pathway responsible for LPS recognition, they establish an environment conducive to a heightened and synergistic immune response. In essence, by initiating multiple toll-like receptor pathways, the system is better equipped to recognize and respond to complex bacterial components, including the LPS of Francisella tularensis. The combinatory effects of these activators ensure that the immune system is on high alert, primed to detect and counteract bacterial intruders effectively.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Polyinosinic-polycytidylic acid potassium salt | 31852-29-6 | sc-202767 | 5 mg | $198.00 | ||
Poly I:C is a synthetic analogue of double-stranded RNA. It activates the TLR3 pathway, which can synergize with the TLR4 response to LPS. | ||||||
Pam3Cys-Ser-(Lys)4, Hydrochloride | 112208-00-1 | sc-507471 | 2 mg | $550.00 | ||
Pam3CSK4 is a synthetic triacylated lipopeptide that activates the TLR1/TLR2 pathway. This can complement the TLR4 pathway, amplifying the response to LPS. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
R848 is an imidazoquinoline compound that activates TLR7 and TLR8, potentially augmenting the TLR4-driven immune response to LPS. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod is another imidazoquinoline that activates TLR7, potentially enhancing the TLR4 response to LPS. | ||||||
Zymosan A from Saccharomyces cerevisiae | 58856-93-2 | sc-258367 sc-258367A | 250 mg 1 g | $90.00 $222.00 | 2 | |
Zymosan, found in yeast cell walls, activates the TLR2/TLR6 pathway, which can synergistically enhance the TLR4-mediated response to LPS. | ||||||